Online Pharmacies: 2026 AI Market Discovery Index

Answer Capsule

In August 2026, AI recommendation power in the online pharmacy category is concentrating around Amazon Pharmacy, which leads with a 38.3% valid recommendation coverage rate and a 17.3% rank-one rate. The strongest challenger is GoodRx, which combines broad presence with strong recommendation conversion. The most exposed group includes traditional pharmacy chains like Walgreens and CVS Pharmacy, which appear frequently in AI responses but convert that presence into top recommendations at significantly lower rates.

For the strategic interpretation of this benchmark, read CiteWorks Studio's analysis of How AI Search Is Recommending Online Pharmacies

Executive Summary

Amazon Pharmacy has established clear AI recommendation leadership in the online pharmacy category. Across 596 observations from six AI platforms, Amazon Pharmacy achieved a 38.3% valid recommendation coverage rate, meaning it earned positive, shortlist-quality recommendations in more than one in three prompts analyzed. Its average recommended rank of 1.79 confirms that when Amazon Pharmacy appears in AI responses, it tends to appear near the top of the list. This combination of frequency and position gives it outsized influence over AI-driven pharmacy selection.

GoodRx represents the strongest challenger in the market. While its raw presence rate of 68.1% trails Amazon Pharmacy's 80.0%, GoodRx converts that presence into valid recommendations more efficiently than most competitors. Its 29.7% valid recommendation coverage and 11.4% top-three rate place it second in recommendation power. A net sentiment score of 0.58 indicates that AI systems frame GoodRx favorably when they mention it, reinforcing its challenger position.

The most commercially significant pattern in this category is the disconnect between presence and recommendation power among traditional pharmacy chains. Walgreens appears in 82.4% of AI responses and CVS Pharmacy in 82.6%, yet both convert that presence into valid recommendations at only a 22.3% rate. Their top-three rates of 9.1% and 12.6% respectively lag well behind Amazon Pharmacy's 25.8%. These brands are being mentioned but not advanced.

Recommendation power matters commercially because AI platforms are becoming active shortlist builders for pharmacy selection. When patients ask which online pharmacy to use, AI systems do not merely list options; they rank them, compare them, and frame them with positive or neutral language. Being mentioned is no longer sufficient. Being recommended, especially in the top three positions, is what drives patient consideration and eventual selection.

The AI Discovery Shift in Online Pharmacies

Traditional pharmacy visibility was built on brand recognition, physical store presence, and search engine dominance. AI platforms disrupt this model by acting as shortlist builders rather than directory listings. When a patient asks an AI assistant which online pharmacy to use, the response typically delivers a ranked list of three to five options with brief justifications. That format compresses the market into a small set of recommended brands, and everything outside that set loses immediate commercial relevance.

The distinction between being mentioned and being advanced is the central dynamic in this category. A brand can appear in an AI response as part of a factual overview, a general market description, or a comparison that the AI uses to illustrate the landscape. That mention creates visibility but does not create recommendation credit. A valid recommendation is a positive, shortlist-quality endorsement that positions the brand as a viable choice for the buyer asking the question. Amazon Pharmacy earns this credit in 38.3% of prompts. Walgreens earns it in 22.3% despite a nearly identical presence rate.

Ranked recommendations matter because position shapes patient behavior. The top three slots in an AI response receive the majority of attention. Amazon Pharmacy's 25.8% top-three rate means it occupies those influential positions at roughly twice the frequency of CVS Pharmacy and nearly three times the frequency of Walgreens. This positioning advantage compounds across thousands of patient queries each month.

Public source evidence is what enables AI systems to recommend confidently. Brands with strong official content, consistent review coverage, and credible comparison-site presence give AI systems the retrievable material needed to construct a well-supported recommendation. Brands that lack this evidence layer may be acknowledged as relevant but are not advanced as preferred choices.

Directional Category Leaders

1. Amazon Pharmacy

Amazon Pharmacy leads the category across every measured recommendation dimension. Its 38.3% valid recommendation coverage rate is the highest in the market. Its 17.3% rank-one rate means it is the first recommendation in more than one in six AI responses. The average recommended rank of 1.79 confirms consistent top-of-list positioning across platforms, and a 52.4% positive visibility rate indicates that AI systems frame it favorably in the majority of mentions.

The public interpretation: Amazon Pharmacy has become the default AI recommendation for online pharmacy selection, and its structural position at the top of AI-generated lists gives it a durable advantage in capturing patient consideration.

2. GoodRx

GoodRx demonstrates the strongest challenger pattern in the category. Its 68.1% presence rate is lower than Amazon Pharmacy's, but its 29.7% valid recommendation coverage shows efficient conversion of visibility into recommendation credit. GoodRx achieves a 11.4% top-three rate and a 4.5% rank-one rate, placing it second in recommendation power across the category. Its net sentiment score of 0.58 reflects consistently positive framing across AI platforms.

The public interpretation: GoodRx has translated its price-comparison authority into credible AI recommendation power, positioning it as the primary alternative when patients ask AI systems for pharmacy guidance.

3. CVS Pharmacy

CVS Pharmacy represents the most visible underperformer relative to its presence. Its 82.6% presence rate is the highest among all measured brands, yet its 22.3% valid recommendation coverage reveals a significant conversion gap. CVS achieves a 12.6% top-three rate and a 3.5% rank-one rate, placing it third in recommendation power despite leading on raw presence. Its net sentiment score of 0.33 is the lowest among major brands, indicating that AI systems frame it less favorably than its footprint would suggest.

The public interpretation: CVS Pharmacy is widely recognized but not strongly recommended, a pattern that suggests AI systems acknowledge its relevance without prioritizing it as a top-tier choice.

4. Walgreens

Walgreens shows the most pronounced presence-to-recommendation gap in the category. Its 82.4% presence rate nearly matches CVS Pharmacy, but its 22.3% valid recommendation coverage and 9.1% top-three rate indicate weak conversion. Most critically, Walgreens achieves a 1.0% rank-one rate, meaning it is almost never the first recommendation in any AI response. Its net sentiment score of 0.34 reflects neutral-to-positive framing that does not translate into recommendation credit.

The public interpretation: Walgreens is being mentioned at scale but not advanced, leaving it structurally vulnerable to displacement by brands that earn consistent top-list positioning.

5. Cost Plus Drugs

Cost Plus Drugs demonstrates strong recommendation quality with more limited presence. Its 45.8% presence rate and 26.3% valid recommendation coverage show efficient conversion, and its 13.9% top-three rate is competitive with CVS Pharmacy. Cost Plus Drugs carries a net sentiment score of 0.75, among the highest in the category, indicating that AI systems frame it positively when they engage with it.

The public interpretation: Cost Plus Drugs earns strong recommendation credit when it appears, but broader presence is needed to convert that recommendation quality into category-level influence.

6. Express Scripts

Express Scripts shows a moderate recommendation profile with notable positive framing. Its 33.9% presence rate and 16.8% valid recommendation coverage place it mid-tier. Express Scripts achieves a 7.7% top-three rate and a 1.9% rank-one rate, with a net sentiment score of 0.69 indicating that AI systems tend to frame it favorably when they mention it.

The public interpretation: Express Scripts has solid recommendation fundamentals but lacks the presence and top-list positioning needed to challenge the category leaders in AI-driven selection.

7. Optum Rx

Optum Rx shows moderate presence with limited recommendation conversion. Its 25.3% presence rate and 13.1% valid recommendation coverage place it in the lower mid-tier. A 0.0% rank-one rate is the most notable signal: Optum Rx is never the first recommendation in any AI response. Its average recommended rank of 3.98 indicates that when recommended, it appears toward the bottom of shortlists.

The public interpretation: Optum Rx is recognized as a relevant option but is not positioned as a leading recommendation, limiting its commercial influence in AI-driven pharmacy selection.

8. PillPack

PillPack functions as a specialized recommendation asset in the category. Its 11.2% presence rate and 10.2% valid recommendation coverage are modest at the category level, but its net sentiment score of 0.97 is the highest measured across all brands. PillPack achieves a 6.4% top-three rate and a 2.4% rank-one rate, indicating strong recommendation quality in the prompts where it appears.

The public interpretation: PillPack captures specialized recommendation moments for medication management and mail-order use cases, reinforcing the Amazon Pharmacy ecosystem in AI responses.

9. Capsule

Capsule shows limited presence with moderate recommendation quality. Its 11.4% presence rate and 7.4% valid recommendation coverage place it in the lower tier. Capsule achieves a 3.2% top-three rate and a 0.8% rank-one rate, with a net sentiment score of 0.81 indicating positive framing when mentioned.

The public interpretation: Capsule has favorable recommendation signals but lacks the presence and scale needed to compete for meaningful AI-driven consideration.

10. Honeybee Health

Honeybee Health shows the most limited recommendation profile in the category. Its 10.1% presence rate and 6.7% valid recommendation coverage are the lowest among measured brands. Honeybee Health achieves a 2.0% top-three rate and a 0.2% rank-one rate, though its net sentiment score of 0.83 indicates positive framing when AI systems do engage with it.

The public interpretation: Honeybee Health earns positive signals when mentioned but lacks the visibility and recommendation coverage to compete for AI-driven patient selection at scale.

The Buying Moments That Now Decide the Category

Best Online Pharmacy Discovery and Evaluation

This cluster covers the primary high-intent buying moment in the category, with 596 observations analyzed across six AI platforms. Prompts include "Which is the most reliable online pharmacy?", "What are the top five pharmacies?", "What is the best online prescription website?", and "Who are the largest mail-order pharmacies?" These prompts capture patients at the consideration stage, actively evaluating which pharmacy to trust before committing to a choice.

Amazon Pharmacy leads this cluster with a 38.3% valid recommendation coverage rate and a 17.3% rank-one rate. GoodRx follows with 29.7% coverage. CVS Pharmacy and Walgreens appear frequently but convert poorly, each at 22.3% recommendation coverage. Because this cluster captures patients before they have committed to a specific pharmacy, recommendation performance here has direct implications for new patient acquisition.

The cluster also includes cost-sensitive prompts such as "What is the cheapest way to get Zepbound without insurance?" and "How much does a Dexcom G7 sensor cost without insurance?" These prompts combine discovery intent with pricing consideration, making them particularly valuable for brands that can demonstrate pricing advantages. Cost Plus Drugs performs competitively in these moments, achieving a 26.3% coverage rate despite lower overall presence, suggesting its pricing-focused positioning resonates with AI systems answering affordability questions.

Why Recommendation Power Is Concentrating

Recommendation power in online pharmacies is concentrating around brands with strong citation architecture. Amazon Pharmacy benefits from extensive official content, broad review coverage, and consistent presence across comparison articles and consumer guides. This evidence layer gives AI systems the retrievable, citable material needed to construct confident recommendations. When an AI system recommends Amazon Pharmacy, it can draw on official documentation, user reviews, and comparison-site content that justify the choice.

GoodRx illustrates how specialized authority translates into recommendation power. Its price-comparison platform generates consistent, citable content that AI systems reference when answering cost-related and affordability prompts. This source visibility gives GoodRx a recommendation advantage that extends well beyond its brand name alone.

Traditional pharmacy chains carry strong brand recognition but weaker recommendation-specific evidence. Their presence in AI responses often derives from general market knowledge rather than specific, citable sources built around recommendation contexts. AI systems can acknowledge these brands as relevant players without having the evidence to advance them as preferred choices. This is why Walgreens and CVS Pharmacy lead on presence but trail on recommendation conversion.

Platform behavior reinforces the concentration effect. AI systems favor brands with clear, consistent, and well-documented positioning across multiple source types, including official content, reviews, comparisons, and community discussions. Brands that appear across this full evidence spectrum give AI systems more material to work with, which tends to result in more frequent and more confident recommendations.

The Category's Most Visible Warning Sign

The most striking pattern in this dataset is the Walgreens presence-to-recommendation gap. Walgreens appears in 82.4% of AI responses, nearly matching Amazon Pharmacy's 80.0% presence rate. The two brands are, by presence alone, roughly equivalent in how often AI systems engage with them. Yet Walgreens earns valid recommendations in 22.3% of prompts while Amazon Pharmacy earns them in 38.3%. At the top of the list, the divergence is sharper: Walgreens achieves a 1.0% rank-one rate against Amazon Pharmacy's 17.3%.

This means AI systems are including Walgreens in factual contexts, market overviews, and general discussions, but are consistently choosing not to advance it as a leading recommendation. For a brand with Walgreens' scale, marketing spend, and consumer recognition, this gap represents a significant and growing loss of influence in the channel where a meaningful share of pharmacy selection decisions are now beginning.

The commercial risk is not hypothetical. Patients who ask AI systems which pharmacy to use are receiving recommendations that consistently favor Amazon Pharmacy and GoodRx. Walgreens appears in those responses, but positioned as a secondary or contextual option rather than a top choice. Repeated exposure to this pattern shapes patient perception over time, and market share follows.

What This Means for the Category

The online pharmacy category is experiencing accelerating shortlist compression. AI systems consistently recommend a narrow set of brands, with Amazon Pharmacy and GoodRx capturing the majority of top-list positions. Brands outside this tier face growing difficulty in reaching patient consideration, regardless of their actual service quality or physical market presence. The shortlist is getting shorter, and the brands in it are pulling further ahead.

Competitor displacement is already visible in the data. Traditional pharmacy chains that built their market positions on brand recognition and store footprint are losing recommendation ground to digitally-native brands with stronger evidence architecture. This displacement is not driven by service quality assessments. It is driven by the structure of AI recommendation systems and the source material those systems can retrieve and cite.

Trust-source dependency is becoming a defining commercial variable. Brands that control their source narrative, maintaining strong official content, positive review coverage, and consistent comparison-site presence, gain a structural advantage in AI-driven selection. Brands that allow gaps in this evidence layer will find themselves acknowledged as relevant but not advanced as preferred choices.

AI discovery is now part of the buyer journey in pharmacy selection. Patients are using AI assistants to research options, compare services, and validate decisions before they ever reach a pharmacy website. Brands that underperform in AI recommendations need stronger entity, content, source, and citation architecture to improve their shortlist eligibility before the gap between presence and recommendation power becomes a gap in market share that is measurable in financial terms.

What This Public Benchmark Does Not Include

This public benchmark provides a directional view of AI recommendation power in the online pharmacy category. The full paid report includes:

• Full cluster dataset across all 10 buyer-intent clusters
• Prompt-level response tables showing exact AI outputs
• Citation-source failure maps identifying where brands lose recommendation credit
• Platform-by-platform recovery priorities across all six AI systems
• Entity and schema diagnostics for technical optimization
• Source-layer gap analysis showing missing evidence types by brand
• Company-specific content recommendations
• Exact competitor threat profiles
• Full paid opportunity model with prioritization framework

This page shows the market shape. The paid report shows the repair map.

Methodology and Disclaimers

Market studied: Online pharmacies, including retail pharmacy chains, mail-order services, digital pharmacy platforms, and pharmacy benefit managers with consumer-facing services.

Brands included: Amazon Pharmacy, Capsule, Cost Plus Drugs, CVS Pharmacy, Express Scripts, GoodRx, Honeybee Health, Optum Rx, PillPack, and Walgreens. This universe covers the major players in the category but is not exhaustive.

Data collection: Data was extracted on August 1, 2026, for the August 2026 reporting month.

AI platforms tested: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.

Prompts tested: 800 total prompts were tested, with 596 eligible prompts included in this analysis.

Prompt scope: The public dataset covers the consideration stage, including discovery and evaluation prompts. The full report includes comparison, pricing, decision, and purchase-stage prompts across all 10 clusters.

Definition of a mention: A mention means the company appeared in an AI-generated response, regardless of sentiment or recommendation status.

Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality endorsement that earns recommendation credit in an AI response. Visibility and recommendation credit are distinct metrics and are not used interchangeably in this report.

Metrics used: Valid recommendation coverage, top-three rate, rank-one rate, top-ten rate, average recommended rank, raw mention presence rate, positive visibility rate, neutral visibility rate, negative visibility rate, and net sentiment score. Monetary metrics from the source data are omitted from this public benchmark.

Limitations: This is a point-in-time benchmark based on AI outputs from August 2026. AI outputs change as models are updated and source material evolves. This report is not a full audit or full market census. Results reflect the AI platforms and prompt set tested and may not represent all buyer journeys or all AI interactions in the category.

Request a Company-Specific Report

For a company-specific Authority Index report, the deeper analysis would show which prompts each company wins or loses, which AI platforms are under-recognizing the brand, which source layers are shaping recommendations, and what changes may improve AI shortlist eligibility.